{
    "organizations": [],
    "uuid": "7f92d0bbc121a104e8c11017d3f3557602d02f6b",
    "author": "",
    "url": "https://www.reuters.com/article/brief-emd-serono-says-health-canada-appr/brief-emd-serono-says-health-canada-approves-bavencio-for-treating-metastatic-merkel-cell-carcinoma-idUSFWN1QC169",
    "ord_in_thread": 0,
    "title": "BRIEF-EMD Serono Says Health Canada Approves BAVENCIO For Treating Metastatic Merkel Cell Carcinoma",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "February 22, 2018 / 7:17 PM / Updated 8 minutes ago BRIEF-EMD Serono Says Health Canada Approves BAVENCIO For Treating Metastatic Merkel Cell Carcinoma Reuters Staff 1 Min Read Feb 22 (Reuters) - EMD Serono: * EMD SERONO - CO, PFIZER CANADA ANNOUNCE HEALTH CANADA APPROVAL FOR BAVENCIO FOR TREATING METASTATIC MERKEL CELL CARCINOMA IN PREVIOUSLY TREATED ADULTS Source text for Eikon: Further company coverage:",
    "published": "2018-02-22T21:14:00.000+02:00",
    "crawled": "2018-02-22T21:36:48.019+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "february",
        "pm",
        "updated",
        "minute",
        "ago",
        "serono",
        "say",
        "health",
        "canada",
        "approves",
        "bavencio",
        "treating",
        "metastatic",
        "merkel",
        "cell",
        "carcinoma",
        "reuters",
        "staff",
        "min",
        "read",
        "feb",
        "reuters",
        "emd",
        "serono",
        "emd",
        "serono",
        "co",
        "pfizer",
        "canada",
        "announce",
        "health",
        "canada",
        "approval",
        "bavencio",
        "treating",
        "metastatic",
        "merkel",
        "cell",
        "carcinoma",
        "previously",
        "treated",
        "adult",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}